|
Depressive disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Impact of age at onset on the phenomenology of depression in treatment-seeking adults in the STAR*D trial.
|
31740109 |
2020 |
|
Depressive disorder
|
0.100 |
Biomarker
|
disease |
BEFREE |
Focusing on insomnia symptoms to better understand depression: A STAR*D report.
|
31499373 |
2020 |
|
Depressive disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Supervised machine-learning methods trained using SNPs and total baseline depression scores predicted remission and response at 8 weeks with area under the receiver operating curve (AUC) > 0.7 (P < 0.04) in PGRN-AMPS patients, with comparable prediction accuracies > 69% (P ≤ 0.07) in STAR*D and ISPC.
|
31012492 |
2019 |
|
Depressive disorder
|
0.100 |
Biomarker
|
disease |
BEFREE |
The STAR*D trial model estimates accurately predicted remission (area under the curve = 0.80) and no meaningful benefit (area under the curve = 0.82) in the Combining Medications to Enhance Depression Outcomes trial and was used to develop an interactive calculator.
|
30958879 |
2019 |
|
Depressive disorder
|
0.100 |
Biomarker
|
disease |
BEFREE |
Latent transition analysis was applied to data from 387 men who completed baseline and Week 12 study visits in Level 1 of STAR*D. Items from the self-report version of the Quick Inventory of Depressive Symptomatology were used as indicators of latent depression subtypes.
|
26438468 |
2018 |
|
Depressive disorder
|
0.100 |
Biomarker
|
disease |
BEFREE |
Patient-reported data on patients with depression from the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial (n = 4039) were used to identify clusters of symptoms in a depressive symptom checklist.
|
28241180 |
2017 |
|
Depressive disorder
|
0.100 |
Biomarker
|
disease |
BEFREE |
SLC6A4 polymorphisms and age of onset in late-life depression on treatment outcomes with citalopram: a Sequenced Treatment Alternatives to Relieve Depression (STAR*D) report.
|
23973251 |
2014 |
|
Depressive disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Linear regressions tested the effect of polygenic risk scores for bipolar disorder on proportional reduction in depression severity in two large samples of individuals with MDD, treated with antidepressants, NEWMEDS (n=1,791) and STAR*D (n=1,107).
|
24339138 |
2014 |
|
Depressive disorder
|
0.100 |
Biomarker
|
disease |
BEFREE |
A meta-analysis was performed on data from three genome-wide pharmacogenetic studies (the Genome-Based Therapeutic Drugs for Depression [GENDEP] project, the Munich Antidepressant Response Signature [MARS] project, and the Sequenced Treatment Alternatives to Relieve Depression [STAR*D] study), which included 2,256 individuals of Northern European descent with major depressive disorder, and antidepressant treatment outcomes were prospectively collected.
|
23377640 |
2013 |
|
Depressive disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Targeted analysis of HTR2A in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study reveals associations between functional variants and depression severity or citalopram response.
|
23158458 |
2013 |
|
Depressive disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Caucasian non-Hispanic participants in the STAR*D study of treatment for depression for whom DNA was available (N = 1213) were genotyped at two single-nucleotide polymorphisms (SNPs) (rs10848635 and rs1006737) in the CACNA1C gene.
|
19388002 |
2010 |
|
Depressive disorder
|
0.100 |
Biomarker
|
disease |
BEFREE |
The influence of genetic variations in SLC6A4 (serotonin transporter gene) on citalopram treatment of depression using the Sequenced Treatment to Relieve Depression (STAR*D) sample was assessed.
|
18618621 |
2009 |
|
Depressive disorder
|
0.100 |
Biomarker
|
disease |
BEFREE |
Income and attrition in the treatment of depression: a STAR*D report.
|
19582825 |
2009 |
|
Depressive disorder
|
0.100 |
Biomarker
|
disease |
BEFREE |
Family history of depression and therapeutic outcome: findings from STAR*D.
|
19192454 |
2009 |
|
Depressive disorder
|
0.100 |
Biomarker
|
disease |
BEFREE |
A total of 339 inpatients with a depressive episode (MARS sample), a further 361 inpatients with depression (German replication sample), and 832 outpatients with major depression (STAR*D sample).
|
19736353 |
2009 |
|
Depressive disorder
|
0.100 |
Biomarker
|
disease |
BEFREE |
The FKBP5-gene in depression and treatment response--an association study in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Cohort.
|
18191112 |
2008 |